1. Home
  2. AVXL vs HIO Comparison

AVXL vs HIO Comparison

Compare AVXL & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$3.81

Market Cap

397.6M

Sector

Health Care

ML Signal

N/A

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

N/A

Current Price

$3.78

Market Cap

368.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AVXL
HIO
Founded
2004
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
397.6M
368.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AVXL
HIO
Price
$3.81
$3.78
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
1.4M
305.3K
Earning Date
02-09-2026
01-01-0001
Dividend Yield
N/A
10.33%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$3.52
52 Week High
$13.99
$4.03

Technical Indicators

Market Signals
Indicator
AVXL
HIO
Relative Strength Index (RSI) 33.16 54.69
Support Level $3.81 $3.74
Resistance Level $5.05 $3.79
Average True Range (ATR) 0.28 0.02
MACD -0.14 0.00
Stochastic Oscillator 2.58 75.00

Price Performance

Historical Comparison
AVXL
HIO

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: